Trump unveils long-promised plan to lower drug prices

President Donald J. Trump said the days of pharmaceutical companies, special interest groups and foreign governments controlling drug pricing are over, as he unveiled his set of proposals for lowering drug prices earlier today — his first public remarks devoted to the issue after often calling it a priority during the first 16 months of his administration. 
His plans call for reversing incentives on list prices, reducing regulatory burden, approving more generics and making sure drug development and financing programs are current to negotiate the best deals possible with drug

Full Story →